NATIONAL DOCTOR’S DAY WEBINAR : COVID-19 PANDEMIC: THE NEW NORMAL DR JUHI NEOGI MBBS(HONS. AND GOLD MEDALIST-COM.MED.) RESIDENT- CRITICAL CARE THE CALCUTTA MEDICAL RESEARCH INSTITUTE
POINTS OF DISCUSSION COVID 19 SIGNS AND SYMPTOMS MANAGEMENT OF MILD , MODERATE AND SEVERE CASES POST-COVID COMPLICATIONS VACCINES : ALL THERE IS TO KNOW PANDEMIC: THEN, NOW, THE TOMORROW
POST- COVID COMPLICATIONS
VACCINES: SPOILT FOR CHOICE NAME OF VACCINE MECH. OF ACTION DOSE EFFICACY COUNTRY Covishield ( ASTRAZENECA) VIRAL VECTOR (MODIFIED CHIMPANZEE ADENOVIRUS) 2 DOSES 8-12 WEEKS APART 70-90% UK & SWEDEN Covaxin INACTIVATED VIRUS 2 DOSES 4 WEEKS APART 70-80% INDIA NOVAVAX PROTEIN BASED 2 DOSES 4 WEEKS APART 85-89% US JOHNSON & JOHNSON/JANSSEN VIRAL VECTOR (HUMAN ADENOVIRUS) 1 DOSE 70-85% USA & BELGIUM
NAME OF VACCINE MECH. OF ACTION DOSE EFFICACY COUNTRY SINOVAC/CORONA VAC INACTIVATED VIRUS 2 DOSES 8 WEEKS APART 67-75% CHINA MODERNA NUCLEOSIDE MODIFIED MRNA 2 DOSES 4 WEEKS APART 90-94% USA SPUTNIK V VIRAL VECTOR (MODIFIED ADENOVIRUS) 2 DOSES 3-13 WEEKS APART 85-90% RUSSIA PFIZER-BIONTECH NUCLEOSIDE MODIFIED MRNA 2 DOSES 3 WEEKS APART 90-94% USA & GERMANY TABLE CONTD…